The Cooper Companies Inc

COO | Healthcare | NASDAQ
$70.46
+1.34 (+1.94%)

Key Metrics

Market Cap
$14.06B
P/E Ratio
34.54
EPS
$2.04
Beta
N/A
Dividend Yield
N/A
ROE
4.97%
Current Ratio
2.12

Company Information

Industry
Medical Instruments Supplies

About The Cooper Companies Inc

The Cooper Companies Inc together with its subsidiaries develops manufactures and markets contact lens wearers The company operates in two segments CooperVision and CooperSurgical The CooperVision segment offers spherical lense including lenses that correct near and farsightedness and toric and multifocal lenses comprising lenses correcting vision challenges such as astigmatism presbyopia myopia ocular dryness and eye fatigues in the Americas Europe Middle East Africa and Asia Pacific The CooperSurgical segment focuses on family and womens health care which provides medical devices fertility genomics diagnostics and contraception to health care professionals and patients worldwide It offers surgical and office products including PARAGARD uterine manipulators retractors closure products point of care products LEEP products endosee and illuminate and fetal pillows fertility products and services such as fertility consumables and equipment and embryo options and preimplantation genetic testing The Cooper Companies Inc was founded in 1958 and is headquartered in San Ramon California

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-27 $1.10 $1.07 +2.8%
2025-05-29 $0.96 $0.93 +3.4%
2025-03-06 $0.92 $0.91 +0.7%
2024-12-05 $1.04 $1.00 +4.0%

Financial Ratios (TTM)

Gross Margin
66.96%
Operating Margin
18.31%
Net Margin
10.08%
ROA
3.29%
Price to Book
1.69
Price to Sales
3.47